325 related articles for article (PubMed ID: 25434988)
1. Oral delivery of capsaicin using MPEG-PCL nanoparticles.
Peng W; Jiang XY; Zhu Y; Omari-Siaw E; Deng WW; Yu JN; Xu XM; Zhang WM
Acta Pharmacol Sin; 2015 Jan; 36(1):139-48. PubMed ID: 25434988
[TBL] [Abstract][Full Text] [Related]
2. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
3. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
4. Toward immunosuppressive effects on liver transplantation in rat model: tacrolimus loaded poly(ethylene glycol)-poly(D,L-lactide) nanoparticle with longer survival time.
Xu W; Ling P; Zhang T
Int J Pharm; 2014 Jan; 460(1-2):173-80. PubMed ID: 24172796
[TBL] [Abstract][Full Text] [Related]
5. Folate-decorated PEG-PLGA nanoparticles with silica shells for capecitabine controlled and targeted delivery.
Wei K; Peng X; Zou F
Int J Pharm; 2014 Apr; 464(1-2):225-33. PubMed ID: 24463073
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin-loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles: preparation, characterization and potential application in corneal transplantation.
Zhang Z; Xu L; Chen H; Li X
J Pharm Pharmacol; 2014 Apr; 66(4):557-63. PubMed ID: 24635557
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
Parikh T; Bommana MM; Squillante E
Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
[TBL] [Abstract][Full Text] [Related]
9. Oral delivery of indinavir using mPEG-PCL nanoparticles: preparation, optimization, cellular uptake, transport and pharmacokinetic evaluation.
Kurd M; Sadegh Malvajerd S; Rezaee S; Hamidi M; Derakhshandeh K
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2123-2133. PubMed ID: 31155961
[No Abstract] [Full Text] [Related]
10. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.
Feng R; Song Z; Zhai G
Int J Nanomedicine; 2012; 7():4089-98. PubMed ID: 22888245
[TBL] [Abstract][Full Text] [Related]
11. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
12. Diclofenac/biodegradable polymer micelles for ocular applications.
Li X; Zhang Z; Li J; Sun S; Weng Y; Chen H
Nanoscale; 2012 Aug; 4(15):4667-73. PubMed ID: 22732776
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Nanoencapsulation of Sepiapterin within PEG-PCL Nanoparticles by Complexation with Triacetyl-Beta Cyclodextrin.
Kuplennik N; Sosnik A
Molecules; 2019 Jul; 24(15):. PubMed ID: 31357400
[TBL] [Abstract][Full Text] [Related]
15. Poly(ester anhydride)/mPEG amphiphilic block co-polymer nanoparticles as delivery devices for paclitaxel.
Liang Y; Xiao L; Li Y; Zhai Y; Xie C; Deng L; Dong A
J Biomater Sci Polym Ed; 2011; 22(4-6):701-15. PubMed ID: 20566053
[TBL] [Abstract][Full Text] [Related]
16. Protein delivery nanosystem of six-arm copolymer poly(ε-caprolactone)-poly(ethylene glycol) for long-term sustained release.
Duan J; Liu C; Liang X; Li X; Chen Y; Chen Z; Wang X; Kong D; Li Y; Yang J
Int J Nanomedicine; 2018; 13():2743-2754. PubMed ID: 29780245
[TBL] [Abstract][Full Text] [Related]
17. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.
Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y
Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
19. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles.
Mady FM; Shaker MA
Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891
[TBL] [Abstract][Full Text] [Related]
20. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
